001     140900
005     20240321220909.0
024 7 _ |a 10.1093/brain/awz050
|2 doi
024 7 _ |a pmid:30897203
|2 pmid
024 7 _ |a pmc:PMC6735903
|2 pmc
024 7 _ |a 0006-8950
|2 ISSN
024 7 _ |a 1460-2156
|2 ISSN
024 7 _ |a altmetric:57485158
|2 altmetric
037 _ _ |a DZNE-2020-07222
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Vöglein, Jonathan
|0 P:(DE-2719)2811820
|b 0
|u dzne
245 _ _ |a Clinical, pathophysiological and genetic features of motor symptoms in autosomal dominant Alzheimer's disease.
260 _ _ |a Oxford
|c 2019
|b Oxford Univ. Press
264 _ 1 |3 online
|2 Crossref
|b Oxford University Press (OUP)
|c 2019-03-20
264 _ 1 |3 print
|2 Crossref
|b Oxford University Press (OUP)
|c 2019-05-01
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1590754383_15073
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Clinical, pathophysiological and genetic features of motor symptoms in autosomal dominant Alzheimer's disease.
536 _ _ |a 342 - Disease Mechanisms and Model Systems (POF3-342)
|0 G:(DE-HGF)POF3-342
|c POF3-342
|f POF III
|x 0
536 _ _ |a 344 - Clinical and Health Care Research (POF3-344)
|0 G:(DE-HGF)POF3-344
|c POF3-344
|f POF III
|x 1
542 _ _ |i 2019-03-21
|2 Crossref
|u https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 2 |a Adult
|2 MeSH
650 _ 2 |a Aged
|2 MeSH
650 _ 2 |a Alzheimer Disease: epidemiology
|2 MeSH
650 _ 2 |a Alzheimer Disease: genetics
|2 MeSH
650 _ 2 |a Alzheimer Disease: physiopathology
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Heterozygote
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Middle Aged
|2 MeSH
650 _ 2 |a Motor Disorders: epidemiology
|2 MeSH
650 _ 2 |a Motor Disorders: genetics
|2 MeSH
650 _ 2 |a Motor Disorders: physiopathology
|2 MeSH
650 _ 2 |a Mutation: genetics
|2 MeSH
700 1 _ |a Paumier, Katrina
|b 1
700 1 _ |a Jucker, Mathias
|0 P:(DE-2719)2000010
|b 2
|u dzne
700 1 _ |a Preische, Oliver
|0 P:(DE-2719)2811828
|b 3
|u dzne
700 1 _ |a McDade, Eric
|b 4
700 1 _ |a Hassenstab, Jason
|b 5
700 1 _ |a Benzinger, Tammie L
|b 6
700 1 _ |a Noble, James M
|b 7
700 1 _ |a Berman, Sarah B
|b 8
700 1 _ |a Graff-Radford, Neill R
|b 9
700 1 _ |a Ghetti, Bernardino
|b 10
700 1 _ |a Farlow, Martin R
|b 11
700 1 _ |a Chhatwal, Jasmeer
|b 12
700 1 _ |a Salloway, Stephen
|b 13
700 1 _ |a Xiong, Chengjie
|b 14
700 1 _ |a Karch, Celeste M
|b 15
700 1 _ |a Cairns, Nigel
|b 16
700 1 _ |a Mori, Hiroshi
|b 17
700 1 _ |a Schofield, Peter R
|b 18
700 1 _ |a Masters, Colin L
|b 19
700 1 _ |a Goate, Alison
|b 20
700 1 _ |a Buckles, Virginia
|b 21
700 1 _ |a Fox, Nick
|b 22
700 1 _ |a Rossor, Martin
|b 23
700 1 _ |a Chrem, Patricio
|b 24
700 1 _ |a Allegri, Ricardo
|b 25
700 1 _ |a Ringman, John M
|b 26
700 1 _ |a Höglinger, Günter
|0 P:(DE-2719)2811373
|b 27
|u dzne
700 1 _ |a Steiner, Harald
|0 P:(DE-2719)2000023
|b 28
|u dzne
700 1 _ |a Dieterich, Marianne
|0 P:(DE-2719)2811918
|b 29
|u dzne
700 1 _ |a Haass, Christian
|0 P:(DE-2719)2202037
|b 30
|u dzne
700 1 _ |a Laske, Christoph
|0 P:(DE-2719)2000055
|b 31
|u dzne
700 1 _ |a Morris, John C
|b 32
700 1 _ |a Bateman, Randall J
|b 33
700 1 _ |a Danek, Adrian
|0 P:(DE-2719)2810712
|b 34
|u dzne
700 1 _ |a Levin, Johannes
|0 P:(DE-2719)2811659
|b 35
|e Last author
|u dzne
700 1 _ |a Network, Dominantly Inherited Alzheimer
|b 36
773 1 8 |a 10.1093/brain/awz050
|b : Oxford University Press (OUP), 2019-03-20
|n 5
|p 1429-1440
|3 journal-article
|2 Crossref
|t Brain
|v 142
|y 2019
|x 0006-8950
773 _ _ |a 10.1093/brain/awz050
|g Vol. 142, no. 5, p. 1429 - 1440
|0 PERI:(DE-600)1474117-9
|n 5
|q 142:5<1429 - 1440
|p 1429-1440
|t Brain
|v 142
|y 2019
|x 0006-8950
856 7 _ |2 Pubmed Central
|u http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6735903
909 C O |o oai:pub.dzne.de:140900
|p VDB
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)2811820
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 2
|6 P:(DE-2719)2000010
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 3
|6 P:(DE-2719)2811828
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 27
|6 P:(DE-2719)2811373
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 28
|6 P:(DE-2719)2000023
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 29
|6 P:(DE-2719)2811918
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 30
|6 P:(DE-2719)2202037
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 31
|6 P:(DE-2719)2000055
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 34
|6 P:(DE-2719)2810712
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 35
|6 P:(DE-2719)2811659
913 1 _ |a DE-HGF
|b Forschungsbereich Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-342
|2 G:(DE-HGF)POF3-300
|v Disease Mechanisms and Model Systems
|x 0
913 1 _ |a DE-HGF
|b Forschungsbereich Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-344
|2 G:(DE-HGF)POF3-300
|v Clinical and Health Care Research
|x 1
914 1 _ |y 2019
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2022-11-09
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2022-11-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2022-11-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2022-11-09
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b BRAIN : 2021
|d 2022-11-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2022-11-09
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2022-11-09
915 _ _ |a IF >= 15
|0 StatID:(DE-HGF)9915
|2 StatID
|b BRAIN : 2021
|d 2022-11-09
920 1 _ |0 I:(DE-2719)1110002
|k AG Höglinger 1
|l Translational Neurodegeneration
|x 0
920 1 _ |0 I:(DE-2719)1210001
|k AG Jucker
|l Cell Biology of Neurologic Diseases
|x 1
920 1 _ |0 I:(DE-2719)1110000-1
|k AG Steiner
|l Biochemistry of γ-Secretase
|x 2
920 1 _ |0 I:(DE-2719)1111016
|k Clinical Dementia Research München
|l Clinical Dementia Research München
|x 3
920 1 _ |0 I:(DE-2719)1110007
|k AG Haass old
|l ALS, FTLD and Zebrafish models
|x 4
920 1 _ |0 I:(DE-2719)7000003
|k U Clinical Researchers - München
|l U Clinical Researchers - München
|x 5
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1110002
980 _ _ |a I:(DE-2719)1210001
980 _ _ |a I:(DE-2719)1110000-1
980 _ _ |a I:(DE-2719)1111016
980 _ _ |a I:(DE-2719)5000015
980 _ _ |a I:(DE-2719)7000003
980 _ _ |a UNRESTRICTED
999 C 5 |a 10.1016/j.jalz.2014.04.514
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.jalz.2014.04.514
999 C 5 |a 10.1186/alzrt59
|9 -- missing cx lookup --
|2 Crossref
|o 10.1186/alzrt59
999 C 5 |a 10.1016/j.jalz.2016.07.005
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.jalz.2016.07.005
999 C 5 |a 10.1056/NEJMoa1202753
|9 -- missing cx lookup --
|2 Crossref
|o 10.1056/NEJMoa1202753
999 C 5 |a 10.1097/WAD.0b013e318142774e
|9 -- missing cx lookup --
|2 Crossref
|o 10.1097/WAD.0b013e318142774e
999 C 5 |y 2004
|2 Crossref
|o Beekly 2004
999 C 5 |a 10.1016/S0140-6736(05)77686-8
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/S0140-6736(05)77686-8
999 C 5 |a 10.1073/pnas.1317918110
|9 -- missing cx lookup --
|2 Crossref
|o 10.1073/pnas.1317918110
999 C 5 |a 10.1111/neup.12205
|9 -- missing cx lookup --
|2 Crossref
|o 10.1111/neup.12205
999 C 5 |a 10.1001/jamaneurol.2015.0606
|9 -- missing cx lookup --
|2 Crossref
|o 10.1001/jamaneurol.2015.0606
999 C 5 |a 10.1002/syn.21566
|9 -- missing cx lookup --
|2 Crossref
|o 10.1002/syn.21566
999 C 5 |y 1987
|2 Crossref
|t Unified Parkinson’s disease rating scale
|o Fahn Unified Parkinson’s disease rating scale 1987
999 C 5 |a 10.1001/jamaneurol.2014.3314
|9 -- missing cx lookup --
|2 Crossref
|o 10.1001/jamaneurol.2014.3314
999 C 5 |a 10.1002/mds.10473
|9 -- missing cx lookup --
|2 Crossref
|o 10.1002/mds.10473
999 C 5 |a 10.1001/archneur.63.3.370
|9 -- missing cx lookup --
|2 Crossref
|o 10.1001/archneur.63.3.370
999 C 5 |a 10.1016/S0002-9440(10)65722-7
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/S0002-9440(10)65722-7
999 C 5 |a 10.1016/S0002-9440(10)64688-3
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/S0002-9440(10)64688-3
999 C 5 |a 10.1038/nrdp.2015.56
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/nrdp.2015.56
999 C 5 |a 10.1212/WNL.0000000000000721
|9 -- missing cx lookup --
|2 Crossref
|o 10.1212/WNL.0000000000000721
999 C 5 |a 10.1212/01.wnl.0000228230.26044.a4
|9 -- missing cx lookup --
|2 Crossref
|o 10.1212/01.wnl.0000228230.26044.a4
999 C 5 |a 10.4155/cli.12.93
|9 -- missing cx lookup --
|2 Crossref
|o 10.4155/cli.12.93
999 C 5 |a 10.1212/WNL.48.6.1508
|9 -- missing cx lookup --
|2 Crossref
|o 10.1212/WNL.48.6.1508
999 C 5 |a 10.1097/01.wad.0000213865.09806.92
|9 -- missing cx lookup --
|2 Crossref
|o 10.1097/01.wad.0000213865.09806.92
999 C 5 |a 10.1093/gerona/59.8.M864
|9 -- missing cx lookup --
|2 Crossref
|o 10.1093/gerona/59.8.M864
999 C 5 |a 10.1097/NEN.0b013e31825018f7
|9 -- missing cx lookup --
|2 Crossref
|o 10.1097/NEN.0b013e31825018f7
999 C 5 |a 10.1146/annurev-neuro-071013-013916
|9 -- missing cx lookup --
|2 Crossref
|o 10.1146/annurev-neuro-071013-013916
999 C 5 |a 10.1001/archneurol.2009.196
|9 -- missing cx lookup --
|2 Crossref
|o 10.1001/archneurol.2009.196
999 C 5 |a 10.1038/s41591-018-0304-3
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/s41591-018-0304-3
999 C 5 |a 10.1093/jnen/nlv028
|9 -- missing cx lookup --
|2 Crossref
|o 10.1093/jnen/nlv028
999 C 5 |a 10.1016/j.neurobiolaging.2015.08.026
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.neurobiolaging.2015.08.026
999 C 5 |a 10.2217/bmm.09.92
|9 -- missing cx lookup --
|2 Crossref
|o 10.2217/bmm.09.92
999 C 5 |a 10.1212/WNL.0000000000000596
|9 -- missing cx lookup --
|2 Crossref
|o 10.1212/WNL.0000000000000596
999 C 5 |a 10.3389/fneur.2015.00142
|9 -- missing cx lookup --
|2 Crossref
|o 10.3389/fneur.2015.00142
999 C 5 |a 10.1016/j.jfma.2015.08.004
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.jfma.2015.08.004
999 C 5 |a 10.1093/brain/awu046
|9 -- missing cx lookup --
|2 Crossref
|o 10.1093/brain/awu046
999 C 5 |a 10.1007/s00401-002-0536-6
|9 -- missing cx lookup --
|2 Crossref
|o 10.1007/s00401-002-0536-6
999 C 5 |a 10.1016/S1474-4422(16)30229-0
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/S1474-4422(16)30229-0
999 C 5 |a 10.1007/s00439-017-1809-4
|9 -- missing cx lookup --
|2 Crossref
|o 10.1007/s00439-017-1809-4
999 C 5 |a 10.1016/S1474-4422(13)70044-9
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/S1474-4422(13)70044-9
999 C 5 |a 10.1016/j.neurobiolaging.2018.11.022
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.neurobiolaging.2018.11.022
999 C 5 |a 10.1093/brain/awp286
|9 -- missing cx lookup --
|2 Crossref
|o 10.1093/brain/awp286
999 C 5 |a 10.1097/WAD.0b013e318191c7dd
|9 -- missing cx lookup --
|2 Crossref
|o 10.1097/WAD.0b013e318191c7dd
999 C 5 |a 10.1016/j.jocn.2009.07.102
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.jocn.2009.07.102


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21